{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal AVB-114",
            "NStudiesAvail": 430108,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "ResultsFirstSubmitDate",
                  "ResultsFirstSubmitQCDate",
                  "RetractionPMID",
                  "RetractionSource",
                  "SamplingMethod",
                  "SecondaryId",
                  "SecondaryIdDomain",
                  "SecondaryIdLink",
                  "SecondaryIdType",
                  "SecondaryOutcomeDescription",
                  "SecondaryOutcomeMeasure",
                  "SecondaryOutcomeTimeFrame",
                  "SeeAlsoLinkLabel",
                  "SeeAlsoLinkURL",
                  "SeriousEventAssessmentType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Length of time fistula meets clinical remission definition.",
                              "Perianal Disease Activity Index (PDAI). Possible scores range from 0-20, with a higher score indicating more severe perianal disease activity",
                              "Short Crohn's Disease Activity Index (sCDAI). Possible scores range from 44 to >450, with a higher score representing more severe disease activity",
                              "Euroqol 5 Dimension 5, level measure of health status (EQ-5D-5L). The scale ranges in scores from 0 to 100, with a higher score indicating a more severe health status.",
                              "Inflammatory Bowel Disease Questionnaire (IBDQ). Possible scores range from 32-224, with a higher score indicating a better health-related quality of life.",
                              "Days of missed work or activity and reason why will be captured.",
                              "Number and type of healthcare resources utilized will be captured."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Change in proportions of subjects with fistula clinical remission between the AVB-114 and standard of care groups.",
                              "Change in the means of durability of clinical remission between the AVB-114 and standard of care groups.",
                              "Change in means of time to clinical remission between the AVB-114 and standard of care groups.",
                              "Change in proportions of subjects with fistula relapse between the AVB-114 and standard of care groups.",
                              "Change in means of time to fistula relapse between the AVB-114 and standard of care groups.",
                              "Change in proportions of radiologic response of treated fistula between the AVB-114 and standard of care groups.",
                              "Change in means of disease activity index scores using the Perianal Disease Activity Index (PDAI) between the AVB-114 and standard of care groups.",
                              "Change in means of disease activity index scores using the short Crohn's Disease Activity Index (sCDAI) between the AVB-114 and standard of care groups.",
                              "Change in means of patient quality of life assessment scores using the Euroqol 5 Diumention 5, level measure of health status (Eq-5Q-5L) between the AVB-114 and standard of care groups.",
                              "Change in means of patient quality of life assessment scores using the Inflammatory Bowel Disease Questionnaire (IBDQ) between the AVB-114 and standard of care groups.",
                              "Change in patient assessment of impact to daily functionality related to treated fistula between the AVB-114 and standard of care groups.",
                              "Change in the evaluations of patient care trajectory related to treated fistula between the AVB-114 and standard of care groups.",
                              "Change in number of adverse events between the AVB-114 and standard of care groups.",
                              "Change in number of serious adverse events between the AVB-114 and standard of care groups."
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "Week 12 to Week 104",
                              "Week 12 to Week 104",
                              "Week 12 to Week 104",
                              "Week 12 to Week 104",
                              "Week 12 to Week 104",
                              "Baseline, Week 12 to Week 52",
                              "Baseline, Week 36",
                              "Baseline, Week 36",
                              "Baseline, Week 36",
                              "Baseline, Week 36",
                              "Baseline, Week 12 to Week 36",
                              "Week 12 to Week 36",
                              "Day 1 to Week 104",
                              "Day 1 to Week 104"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04847739"
                        ]
                  }
            ]
      }
}